Align Technology (ALGN) Competitors $131.39 -1.18 (-0.89%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$131.65 +0.26 (+0.20%) As of 09/19/2025 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALGN vs. DXCM, HQY, HSIC, MEDP, QTRX, CAH, HAE, MCK, RMD, and WSTShould you be buying Align Technology stock or one of its competitors? The main competitors of Align Technology include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Medpace (MEDP), Quanterix (QTRX), Cardinal Health (CAH), Haemonetics (HAE), McKesson (MCK), ResMed (RMD), and West Pharmaceutical Services (WST). These companies are all part of the "medical" sector. Align Technology vs. Its Competitors DexCom HealthEquity Henry Schein Medpace Quanterix Cardinal Health Haemonetics McKesson ResMed West Pharmaceutical Services Align Technology (NASDAQ:ALGN) and DexCom (NASDAQ:DXCM) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings. Is ALGN or DXCM more profitable? DexCom has a net margin of 13.29% compared to Align Technology's net margin of 11.04%. DexCom's return on equity of 30.41% beat Align Technology's return on equity.Company Net Margins Return on Equity Return on Assets Align Technology11.04% 13.36% 8.32% DexCom 13.29%30.41%10.08% Do institutionals and insiders believe in ALGN or DXCM? 88.4% of Align Technology shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 0.7% of Align Technology shares are held by company insiders. Comparatively, 0.3% of DexCom shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more volatility and risk, ALGN or DXCM? Align Technology has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500. Comparatively, DexCom has a beta of 1.48, indicating that its share price is 48% more volatile than the S&P 500. Which has better valuation & earnings, ALGN or DXCM? DexCom has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlign Technology$4.00B2.38$421.36M$5.9322.16DexCom$4.03B6.56$576.20M$1.4446.84 Does the media refer more to ALGN or DXCM? In the previous week, DexCom had 15 more articles in the media than Align Technology. MarketBeat recorded 33 mentions for DexCom and 18 mentions for Align Technology. Align Technology's average media sentiment score of 1.17 beat DexCom's score of 1.17 indicating that Align Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 12 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 18 Very Positive mention(s) 1 Positive mention(s) 11 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate ALGN or DXCM? Align Technology presently has a consensus price target of $215.00, indicating a potential upside of 63.63%. DexCom has a consensus price target of $99.89, indicating a potential upside of 48.10%. Given Align Technology's higher probable upside, research analysts clearly believe Align Technology is more favorable than DexCom.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Align Technology 2 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.50DexCom 0 Sell rating(s) 5 Hold rating(s) 14 Buy rating(s) 3 Strong Buy rating(s) 2.91 SummaryDexCom beats Align Technology on 12 of the 17 factors compared between the two stocks. Get Align Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALGN vs. The Competition Export to ExcelMetricAlign TechnologyMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.61B$16.94B$5.79B$10.40BDividend YieldN/A1.58%5.63%4.60%P/E Ratio22.1617.0276.4826.75Price / Sales2.382.30531.72124.23Price / Cash14.7512.9437.9261.55Price / Book2.553.3113.726.40Net Income$421.36M$472.94M$3.29B$271.62M7 Day Performance-0.13%-2.87%2.66%3.46%1 Month Performance-8.49%-7.83%6.02%9.87%1 Year Performance-48.04%-5.65%80.02%28.45% Align Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALGNAlign Technology4.9533 of 5 stars$131.39-0.9%$215.00+63.6%-48.9%$9.61B$4.00B22.1620,945Positive NewsDXCMDexCom4.9781 of 5 stars$75.58-0.8%$99.89+32.2%-6.2%$29.64B$4.30B52.4910,300Trending NewsOptions VolumeHQYHealthEquity4.4696 of 5 stars$93.02+0.6%$119.77+28.8%+19.3%$8.01B$1.20B56.383,120Positive NewsHSICHenry Schein3.9329 of 5 stars$68.81-0.3%$76.67+11.4%-6.5%$8.34B$12.77B22.2025,000Positive NewsAnalyst RevisionMEDPMedpace4.3129 of 5 stars$496.41+1.2%$422.27-14.9%+35.1%$13.94B$2.11B36.915,900Positive NewsQTRXQuanterix1.7924 of 5 stars$4.97+3.3%$11.75+136.4%-64.9%$230.96M$137.42M-2.73460Positive NewsCAHCardinal Health4.9628 of 5 stars$150.45-1.2%$165.93+10.3%+35.0%$35.93B$222.58B23.3357,700Positive NewsHAEHaemonetics4.9402 of 5 stars$51.39-1.6%$78.78+53.3%-32.7%$2.48B$1.35B15.723,023MCKMcKesson4.6585 of 5 stars$702.38-1.3%$725.10+3.2%+37.4%$87.36B$359.05B28.0145,000Positive NewsAnalyst DowngradeRMDResMed4.7463 of 5 stars$271.39+0.5%$278.36+2.6%+12.6%$39.74B$5.15B28.5410,600Positive NewsAnalyst ForecastWSTWest Pharmaceutical Services4.9898 of 5 stars$257.73+1.7%$319.50+24.0%-18.1%$18.53B$2.89B38.5810,600Positive News Related Companies and Tools Related Companies DXCM Alternatives HQY Alternatives HSIC Alternatives MEDP Alternatives QTRX Alternatives CAH Alternatives HAE Alternatives MCK Alternatives RMD Alternatives WST Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALGN) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredWhy silver could go 100X higherInflation is destroying purchasing power at 10–14% per year. Gold will protect you — but not the way you think...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Align Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Align Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALGN Stock Alerts